Trial · NCT02601937
Adverse events4,026
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 4,026
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Otitis media | Infections and infestations | Dose Escalation Level 1 | 1 | 8 | 1 |
| other | Otitis media | Infections and infestations | Dose Escalation Level 2 | 1 | 6 | 2 |
| other | Otitis media | Infections and infestations | Dose Escalation Level 3 | 0 | 6 | 0 |
| other | Otitis media | Infections and infestations | Dose Escalation Level 4 | 1 | 7 | 2 |
| other | Otitis media | Infections and infestations | Dose Escalation Level 5 | 1 | 6 | 1 |
| other | Otitis media | Infections and infestations | Dose Escalation Level 6 | 1 | 6 | 1 |
| other | Otitis media | Infections and infestations | Dose Escalation Level 7 | 0 | 7 | 0 |
| other | Otitis media | Infections and infestations | Dose Expansion Cohort 1 | 3 | 19 | 3 |
| other | Otitis media | Infections and infestations | Dose Expansion Cohort 2 | 0 | 20 | 0 |
| other | Otitis media | Infections and infestations | Dose Expansion Cohort 3 | 0 | 18 | 0 |
| other | Otitis media | Infections and infestations | Dose Expansion Cohort 4 | 0 | 6 | 0 |
| other | Upper respiratory tract infection | Infections and infestations | Dose Escalation Level 1 | 0 | 8 | 0 |
| other | Upper respiratory tract infection | Infections and infestations | Dose Escalation Level 2 | 0 | 6 | 0 |
| other | Upper respiratory tract infection | Infections and infestations | Dose Escalation Level 3 | 0 | 6 | 0 |
| other | Upper respiratory tract infection | Infections and infestations | Dose Escalation Level 4 | 2 | 7 | 9 |
| other | Upper respiratory tract infection | Infections and infestations | Dose Escalation Level 5 | 1 | 6 | 1 |
| other | Upper respiratory tract infection | Infections and infestations | Dose Escalation Level 6 | 1 | 6 | 2 |
| other | Upper respiratory tract infection | Infections and infestations | Dose Escalation Level 7 | 1 | 7 | 1 |
| other | Upper respiratory tract infection | Infections and infestations | Dose Expansion Cohort 1 | 2 | 19 | 3 |
| other | Upper respiratory tract infection | Infections and infestations | Dose Expansion Cohort 2 | 1 | 20 | 1 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02601937/events